AHA19 Scientific Sessions came to an end last month and we all went back to our homes, but the discussions continued, especially concerning the ISCHEMIA Trial. The study design was very simple (Figure 1). This is a randomized parallel study of patients with stable coronary artery disease and moderate to severe ischemia. Ischemia was defined … Read more
The recently concluded AHA Scientific Sessions provided for a myriad of sessions on antiplatelet therapy in cardiovascular disease (CVD). The late-breaking TWILIGHT ACS trial reported a win for ticagrelor monotherapy among patients randomized after 3 months post-NSTE-ACS and PCI, in results consistent with the main TWILIGHT trial.1-2 TWILIGHT ACS showed a reduction of clinically significant … Read more
As we’ve all been back from AHA19 for a few weeks now, I began thinking about the research presented. Throughout the conference I tried to focus on topics of aging and cardiovascular disease, which is my current research focus. I kept finding myself in front of posters or at talks on metabolism and my personal … Read more
“Skate to where the puck is going, not where it has been.” -Wayne Gretzky, Hall of Fame Hockey Player I heard this quote a few times at #AHA19, most relevantly during a special interest “breakout” session for Advanced Heart Failure & Transplant Cardiology held in the AHA Early Career / FIT Lounge. In reflecting on … Read more
Throughout my career, I’ve been coached that mentorship is the key to success. I found this to be true throughout my doctoral education, during my stint as a research consultant in industry, as a research fellow in a primarily clinical fellowship, and, now, as junior faculty. I won’t say that I’ve mastered mentorship (or being … Read more
Some of the highlights of AHA19 for me include seeing the support that the AHA and many established cardiovascular leaders who are part of the AHA give to early career investigators and to see some of the amazing work completed by trainees. Specifically in the Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation (3CPR), there … Read more
Created in 2006, Twitter became a new form of social media. I joined, but wasn’t very active. If someone were to have told me that tweeting would be a way for me to stay up to date in my field of pediatric cardiology, to network with people professionally and to share in experience with a … Read more
The past few years have witnessed the emergence of many technological advances that hold promises for potentially revolutionizing the way we are treating patients with cardiac arrhythmias. Between innovative technologies for cardiac pacemakers and defibrillators, breakthroughs in ablation of atrial and ventricular arrhythmias, and boundless progress in remote monitoring of cardiac rhythm, the field of … Read more
AHA19 was a tremendous meeting for many reasons – extraordinary science, inspirational attendees, performances from the cast of Hamilton, and all in my current home of Philadelphia! Sessions 2019 was also unique for its deliberate approach to the inclusion of women in cardiovascular and neurovascular medicine. I was impressed by the breadth and depth of … Read more
The American Heart Association’s Scientific Sessions is one of the biggest conferences in cardiology. It draws students, residents, fellows, affiliate practitioners, attendings, researchers, and so many more. Therefore, attending a conference of this caliber is a big deal! The event is full of intense information. New ideas. New contacts. New solutions. And, new found energy. … Read more